Disturbance of consciousness and involuntary movements caused by pregabalin. 2012

Taro Shimizu, and Tsuneyasu Yoshida, and Koichi Kitamura, and Osamu Hamada
Department of General Medicine, Nerima Hikarigaoka Hospital, Tokyo, Japan. shimizutaro7@gmail.com

A 91-year-old man with chronic low-back pain presented with 1-day history of disturbance of consciousness and myoclonus of all of his extremities and face. Laboratory examinations revealed no abnormalities. Administration of benzodiazepine for the myoclonus resulted in immediate and complete disappearance of the symptoms. He recently started taking pregabalin (Lyrica capsules) which was prescribed for low-back pain 3 days ago. The day following admission, he discontinued pregabalin. He did not experience recurrence of his symptoms any more. We concluded that the neurological symptoms he experienced were possibly due to pregabalin.

UI MeSH Term Description Entries
D008297 Male Males
D009207 Myoclonus Involuntary shock-like contractions, irregular in rhythm and amplitude, followed by relaxation, of a muscle or a group of muscles. This condition may be a feature of some CENTRAL NERVOUS SYSTEM DISEASES; (e.g., EPILEPSY, MYOCLONIC). Nocturnal myoclonus is the principal feature of the NOCTURNAL MYOCLONUS SYNDROME. (From Adams et al., Principles of Neurology, 6th ed, pp102-3). Myoclonus, Action,Myoclonus, Nocturnal,Myoclonus, Palatal,Polymyoclonus,Myoclonic Jerk,Myoclonic Jerking,Myoclonus Simplex,Myoclonus, Eyelid,Myoclonus, Intention,Myoclonus, Lower Extremity,Myoclonus, Oculopalatal,Myoclonus, Segmental,Myoclonus, Sleep,Myoclonus, Upper Extremity,Action Myoclonus,Extremity Myoclonus, Lower,Extremity Myoclonus, Upper,Eyelid Myoclonus,Intention Myoclonus,Jerk, Myoclonic,Jerking, Myoclonic,Jerks, Myoclonic,Lower Extremity Myoclonus,Myoclonic Jerks,Nocturnal Myoclonus,Oculopalatal Myoclonus,Palatal Myoclonus,Segmental Myoclonus,Simplex, Myoclonus,Sleep Myoclonus,Upper Extremity Myoclonus
D003244 Consciousness Disorders Organic mental disorders in which there is impairment of the ability to maintain awareness of self and environment and to respond to environmental stimuli. Dysfunction of the cerebral hemispheres or brain stem RETICULAR FORMATION may result in this condition. Consciousness, Level Altered,Disorder of Consciousness,Disorders of Consciousness,Semiconsciousness,Altered Level of Consciousness,Consciousness, Level Depressed,Depressed Level of Consciousness,Consciousness Disorder
D003975 Diazepam A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity. 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one,Apaurin,Diazemuls,Faustan,Relanium,Seduxen,Sibazon,Stesolid,Valium
D005680 gamma-Aminobutyric Acid The most common inhibitory neurotransmitter in the central nervous system. 4-Aminobutyric Acid,GABA,4-Aminobutanoic Acid,Aminalon,Aminalone,Gammalon,Lithium GABA,gamma-Aminobutyric Acid, Calcium Salt (2:1),gamma-Aminobutyric Acid, Hydrochloride,gamma-Aminobutyric Acid, Monolithium Salt,gamma-Aminobutyric Acid, Monosodium Salt,gamma-Aminobutyric Acid, Zinc Salt (2:1),4 Aminobutanoic Acid,4 Aminobutyric Acid,Acid, Hydrochloride gamma-Aminobutyric,GABA, Lithium,Hydrochloride gamma-Aminobutyric Acid,gamma Aminobutyric Acid,gamma Aminobutyric Acid, Hydrochloride,gamma Aminobutyric Acid, Monolithium Salt,gamma Aminobutyric Acid, Monosodium Salt
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069583 Pregabalin A gamma-aminobutyric acid (GABA) derivative that functions as a CALCIUM CHANNEL BLOCKER and is used as an ANTICONVULSANT as well as an ANTI-ANXIETY AGENT. It is also used as an ANALGESIC in the treatment of NEUROPATHIC PAIN and FIBROMYALGIA. (R-)-3-isobutyl GABA,(S)-3-(aminomethyl)-5-methylhexanoic acid,(S+)-3-isobutyl GABA,3-(aminomethyl)-5-methylhexanoic acid,3-isobutyl GABA,CI 1008,CI-1008,Lyrica,1008, CI,3 isobutyl GABA,CI1008,GABA, 3-isobutyl
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D000700 Analgesics Compounds capable of relieving pain without the loss of CONSCIOUSNESS. Analgesic,Anodynes,Antinociceptive Agents,Analgesic Agents,Analgesic Drugs,Agents, Analgesic,Agents, Antinociceptive,Drugs, Analgesic
D018757 GABA Modulators Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here. gamma-Aminobutyric Acid Modulators,GABAergic Modulators,Acid Modulators, gamma-Aminobutyric,Modulators, GABA,Modulators, GABAergic,Modulators, gamma-Aminobutyric Acid,gamma Aminobutyric Acid Modulators

Related Publications

Taro Shimizu, and Tsuneyasu Yoshida, and Koichi Kitamura, and Osamu Hamada
December 2017, Diabetic medicine : a journal of the British Diabetic Association,
Taro Shimizu, and Tsuneyasu Yoshida, and Koichi Kitamura, and Osamu Hamada
January 1984, [Kango gijutsu] : [Nursing technique],
Taro Shimizu, and Tsuneyasu Yoshida, and Koichi Kitamura, and Osamu Hamada
August 1994, Rinsho shinkeigaku = Clinical neurology,
Taro Shimizu, and Tsuneyasu Yoshida, and Koichi Kitamura, and Osamu Hamada
January 2013, The Journal of neuropsychiatry and clinical neurosciences,
Taro Shimizu, and Tsuneyasu Yoshida, and Koichi Kitamura, and Osamu Hamada
March 1975, Journal of neurology, neurosurgery, and psychiatry,
Taro Shimizu, and Tsuneyasu Yoshida, and Koichi Kitamura, and Osamu Hamada
April 1971, Shinkei kenkyu no shimpo. Advances in neurological sciences,
Taro Shimizu, and Tsuneyasu Yoshida, and Koichi Kitamura, and Osamu Hamada
January 2024, BMC anesthesiology,
Taro Shimizu, and Tsuneyasu Yoshida, and Koichi Kitamura, and Osamu Hamada
January 1915, Proceedings of the Royal Society of Medicine,
Taro Shimizu, and Tsuneyasu Yoshida, and Koichi Kitamura, and Osamu Hamada
May 1997, No to hattatsu = Brain and development,
Taro Shimizu, and Tsuneyasu Yoshida, and Koichi Kitamura, and Osamu Hamada
November 1972, Journal of the Irish Medical Association,
Copied contents to your clipboard!